# LifeMD Inc. (LFMD)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $224M  
**Price:** $4.96 (-0.30%)

> LifeMD Inc. is a direct-to-patient telehealth company that provides virtual primary care services and pharmacy solutions in the United States. It connects consumers to healthcare professionals through a platform featuring clinician-centric electronic medical records, remote lab testing, digital prescriptions, audio/video consultations, and cloud pharmacy fulfillment. Key brands include RexMD for men's health conditions such as erectile dysfunction, premature ejaculation, and hair loss, and ShapiroMD for virtual treatments and prescription medications. The company offers weight management programs with access to GLP-1 medications like Wegovy and Ozempic through collaborations with pharmaceutical partners, alongside nutritional supplements and over-the-counter products. Following the divestiture of its WorkSimpli software segment, LifeMD Inc. operates as a pure-play virtual care and pharmacy platform, emphasizing telehealth services that deliver convenient, cost-effective healthcare access. Headquartered in New York, NY, it leverages expertise in medicine, technology, marketing, and operations to serve patients seeking on-demand care.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $194M | $166M | -$8M | $14M | — |
| 2024 | $155M | $133M | -$20M | -$21M | — |
| 2023 | $153M | $134M | -$14M | -$21M | — |
| 2022 | $119M | $100M | -$43M | -$46M | — |
| 2021 | $93M | $75M | -$54M | -$61M | — |
| 2020 | $37M | $28M | -$58M | -$59M | — |
| 2019 | $12M | $10M | -$3M | -$3M | — |
| 2018 | $42,515 | $6M | -$2M | -$1M | — |
| 2017 | $4M | $3M | -$1M | -$1M | — |
| 2016 | $5M | $3M | -$1M | -$1M | — |
| 2015 | $1M | $971,090 | -$262,217 | -$61,992 | — |
| 2014 | $714,158 | $541,308 | -$530,879 | -$460,485 | — |
| 2013 | $808,363 | $627,059 | -$546,408 | -$268,262 | — |
| 2012 | $673,778 | $473,870 | -$540,025 | -$445,649 | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $70M | $47M | $23M | — | — |
| 2024 | $76M | $84M | -$9M | $35M | — |
| 2023 | $58M | $53M | $4M | $33M | — |
| 2022 | $26M | $33M | -$11M | $4M | — |
| 2021 | $50M | $24M | $23M | $41M | — |
| 2020 | $13M | $14M | -$2M | $9M | — |
| 2019 | $3M | $5M | -$988,185 | $1M | — |
| 2018 | $3M | $2M | $897,700 | $180,093 | — |
| 2017 | $1M | $640,971 | $881,923 | $141,379 | — |
| 2016 | $789,824 | $1M | -$355,170 | $182,561 | — |
| 2015 | $448,471 | $267,481 | $100,078 | $232,984 | — |
| 2014 | $175,221 | $314,719 | -$139,498 | $75,495 | — |
| 2013 | $551,449 | $355,962 | $195,487 | $155,056 | — |
| 2012 | $369,695 | $234,696 | $134,999 | $98,930 | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $8M | $2M | $6M |
| 2024 | $18M | $1M | $16M |
| 2023 | $9M | $203,814 | $9M |
| 2022 | -$23M | $366,633 | -$23M |
| 2021 | -$33M | $247,365 | -$33M |
| 2020 | -$12M | — | — |
| 2019 | $251,408 | — | — |
| 2018 | -$905,519 | — | — |
| 2017 | -$817,216 | — | — |
| 2016 | -$407,914 | — | — |
| 2015 | -$295,124 | — | — |
| 2014 | $33,439 | — | — |
| 2013 | -$259,074 | — | — |
| 2012 | -$229,726 | — | — |

Source: [CompaniesByCap](https://companiesbycap.com/company/LFMD)